Inflammatory activity at school age in very low birth weight bronchopulmonary dysplasia survivors

Pediatric Pulmonology

Volumn 50, Issue 7, 2015, Pages 683-690

  Korhonen, Päivi H ^a   Suursalmi, Piia H ^a   Kopeli, Tarja ^b   Nieminen, Riina ^c   Lehtimäki, Lauri ^a,c   Luukkaala, Tiina ^c   Korppi, Matti ^a   Saari, Antti ^d   Moilanen, Eeva ^c   Tammela, Outi K T ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

adipokine; body mass index; exhaled breath; interleukin; nitric oxide; premature infant

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; COMPLEMENT FACTOR D; EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; LEUKOTRIENE B4; RESISTIN; TOBACCO SMOKE; BIOLOGICAL MARKER; GLUCOCORTICOID;

ARTICLE; ATOPY; BODY MASS; CHILD; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DOMESTIC ANIMAL; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; LUNG DYSPLASIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; RISK REDUCTION; SCHOOL CHILD; VERY LOW BIRTH WEIGHT; ADOLESCENT; ASTHMA; BLOOD; BRONCHOPULMONARY DYSPLASIA; FINLAND; NEWBORN; PREGNANCY; STATISTICAL MODEL; SURVIVOR;

ADIPONECTIN; ADOLESCENT; ASTHMA; BIOMARKERS; BODY MASS INDEX; BRONCHOPULMONARY DYSPLASIA; CHILD; CHORIOAMNIONITIS; COMPLEMENT FACTOR D; FEMALE; FINLAND; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTERLEUKIN-6; INTERLEUKIN-8; LEPTIN; LOGISTIC MODELS; PREGNANCY; SURVIVORS;

EID: 84947030962     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23038     Document Type: Article

References (30)

1. Ambalavanan N, Carlo WA, D'Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD,. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009; 123: 1132-1141.
2. Beresford MW, Shaw NJ,. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 2002; 52: 973-978.
3. May C, Williams O, Milner AD, Peacock J, Rafferty GF, Hannam S, Greenough A,. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2009; 94: F205-F209.
4. May C, Patel S, Kennedy C, Pollina E, Rafferty GF, Peacock JL, Greenough A,. Prediction of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2011; 96: F410-F416.
5. Hennessy EM, Bracewell MA, Wood N, Wolke D, Costeloe K, Gibson A, Marlow N,. and for the EPICure study group. Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child 2008; 93: 1037-1043.
6. Greenough A,. Long term respiratory outcomes of very premature birth (<32 weeks). Semin Fetal Neonatal Med 2012; 17: 73-76.
7. Pelkonen AS, Hakulinen AL, Hallman M, Turpeinen M,. Effect of inhaled budenoside therapy on lung function in schoolchildren born preterm. Respir Med 2001; 95: 565-570.
8. Allen J, Zwerdling R, Ehrenkranz R, Gaultier G, Geggel R, Greenough A, Kleinman R, Klijanowicz A, Martinez F, Ozdemir A, et al., Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168: 356-396.
9. Kunzmann S, Collins JJP, Kuypers E, Kramer BW,. Thrown off balance: the effect of antenatal inflammation on the developing lung and immune system. Am J Obstet Gynecol 2013; 208: 429-437. http://dx.doi.org/10.1016/j.ajog2013.01.008.
10. Dodig S, Richter D, Zrinski-Topic R,. Inflammatory markers in childhood asthma. Clin Chem Lab Med 2011; 49: 587-599.
11. Hyvärinen MK, Kotaniemi-Syrjänen A, Reijonen TM, Piippo-Savolainen E, Korppi M,. Eosinophil activity in infants hospitalized for wheezing and risk of persistent childhood asthma. Pediatr Allergy Immunol 2010; 21: 96-103.
12. Maury E, Brichard SM,. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cellular Endocrinol 2010; 314: 1-16.
13. Baek HS, Kim YD, Shin JH, Kim JH, Oh JW, Lee HB,. Serum leptin and adiponectin levels correlate with exercise-induced bronchoconstriction in children with asthma. Ann Allergy Asthma Immunol 2011; 107: 14-21.
14. Yuksel H, Sogut A, Yilmaz O, Onur E, Dinc G,. Role of adipokines and hormones of obesity in childhood asthma. Allergy Asthma Immunol 2012; 4: 98-103.
15. Lum S, Kirkby J, Welsh L, Marlow N, Hennessy E, Stocks J,. Nature and severity of lung function abnormalities in extremely preterm children at 11 years of age. Eur Respir J 2011; 37: 1199-1207.
16. Malmberg LP, Pelkonen AS, Malmström K, Saarinen KM, Kajosaari M, Hakulinen A, Mäkelä MJ,. Very low birth weight and respiratory outcome: association between airway inflammation and hyperresponsiveness. Ann Allergy Asthma Immunol 2013; 11: 96-101.
17. Baraldi E, Bonetto G, Zacchello F, Filippone M,. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med 2005; 171: 68-72.
18. Linkosalo L, Lehtimäki L, Holm K, Kaila M, Moilanen E,. Relation of bronchial and alveolar nitric oxide to exercise-induced bronchoconstriction in atopic children and adolescents. Pediatr Allergy Immunol 2012; 23: 360-366.
19. Northway WH, Rosan RC, Porter DY,. Pulmonary disease following respiratory therapy of hyaline-membrane disease-bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
20. Pihkala J, Hakala T, Voutilainen P, Raivio K,. Uudet suomalaiset sikiön kasvukäyrät. Duodecim 1989; 105: 1540-1546.
21. Saari A, Sankilampi U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L,. New Finnish growth references for children and adolescents aged 0-20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med 2011; 43: 235-248.
22. Csonka P, Kaila M, Laippala P, Kuusela AL, Ashorn P,. Wheezing in early life and asthma at school age: predictors of symptom persistence. Pediatr Allergy Immunol 2000; 11: 225-229.
23. Central Statistical Office of Finland. 1989, Classification of socio-economic groups 1989, Helsinki.
24. Tsoukias NM, George SC,. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998; 85: 653-666.
25. Cibella F, Cuttitta G, La Grutta S, Melis MR, Bucchieri S, Viegi G,. A cross-sectional study assessing the relationship between BMI, asthma, atopy, and eNO among schoolchildren. Ann Allergy Asthma Immunol 2011; 107: 330-336.
26. Santamaria F, Montella S, De Stefano S, Sperl F, Barbarana F, Valerio G,. Relationship between exhaled nitric oxide and body mass index in children and adolescents. J Allergy Clin Immunol 2005; 116: 1163-1164.
27. Laoudi Y, Nikasinovich L, Sahraoui F, Grimfeld A, Momas I, Just J,. Passive smoking is a major determinant of exhaled nitric oxide levels in allergic asthmatic children. Allergy 2010; 65: 491-497.
28. Tardif J, Borgeat P, Laviolette M,. Inhibition of human alveolar macrophage production of leukotriene B4 by acute in vitro and in vivo exposure to tobacco smoke. Am J Respir Cell Mol Biol 1990; 2: 155-161.
29. Goksör E, Amark M, Alm B, Gustafsson PM, Wennergren G,. Asthma symptoms in early childhood-what happens then ? Acta Paediatr 2006; 95: 471-478.
30. Walsh MC, Yao Q, Gettner P, Hall E, Collins M, Hensman A, Everette R, Peters N, Miller N, Muran G, et al., Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114: 1305-1311.